The store will not work correctly when cookies are disabled.
(4-amino-2-(pyridin-3-ylamino)thiazol-5-yl)(2-fluorophenyl)methanone
ID: ALA1761791
Cas Number: 1289638-15-8
PubChem CID: 54581340
Max Phase: Preclinical
Molecular Formula: C15H11FN4OS
Molecular Weight: 314.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1F
Standard InChI: InChI=1S/C15H11FN4OS/c16-11-6-2-1-5-10(11)12(21)13-14(17)20-15(22-13)19-9-4-3-7-18-8-9/h1-8H,17H2,(H,19,20)
Standard InChI Key: XHJMMMPXTUEBMQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
20.0416 -13.7334 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.8666 -13.7334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1234 -12.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4541 -12.4625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7891 -12.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3508 -14.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0143 -15.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1714 -14.3161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9084 -12.6954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0044 -12.6946 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3915 -13.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6076 -12.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9951 -13.5414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1668 -14.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9564 -14.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5655 -14.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1927 -15.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8563 -15.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3406 -16.6568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1651 -16.5685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4978 -15.8158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3180 -15.7272 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10 11 1 0
1 2 1 0
11 12 2 0
2 6 1 0
12 13 1 0
13 14 2 0
6 7 1 0
14 15 1 0
2 3 2 0
15 16 2 0
16 11 1 0
6 8 2 0
7 17 2 0
3 4 1 0
17 18 1 0
3 9 1 0
18 19 2 0
4 5 2 0
19 20 1 0
5 10 1 0
20 21 2 0
21 7 1 0
5 1 1 0
21 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.35 | Molecular Weight (Monoisotopic): 314.0638 | AlogP: 3.23 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.88 | CX Basic pKa: 5.30 | CX LogP: 3.69 | CX LogD: 3.69 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.72 | Np Likeness Score: -2.03 |
References
1. Laha JK, Zhang X, Qiao L, Liu M, Chatterjee S, Robinson S, Kosik KS, Cuny GD.. (2011) Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors., 21 (7): [PMID:21353545] [10.1016/j.bmcl.2011.01.140] |